Navigation Links
QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
Date:8/22/2007

need for women and for physicians seeking alternatives to hormone therapies."

Dr. Alan Altman, Assistant Clinical Professor of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School and an expert on menopause, commented "Physicians are now seeing an epidemic of vaginal symptoms, such as dryness, irritation and sexual pain, in post-menopausal patients as a result of large numbers of women stopping hormone treatment due to fear instilled by what they have read about the Women's Health Initiative Study. Chronic symptoms such as these have a major adverse impact on quality of life for these women and highlight the need for new treatment options in those wanting to avoid estrogen use."

About Postmenopausal Vaginal Syndrome

Postmenopausal Vaginal Syndrome (PVS) is a chronic condition characterized by vaginal symptoms including dryness, sexual pain (dyspareunia), and irritation. Declining estrogen levels during menopause may cause tissues of the vaginal lining to grow thinner and to lose elasticity, a condition known as atrophy. Dryness and irritation associated with decreases in vaginal secretions often cause pain or bleeding during sexual intercourse. The decline in estrogen also contributes to an increase in vaginal pH, creating an environment more susceptible to infection. There are more than 64 million women in the United States who are over 40 years old. It is estimated that up to 40% of post-menopausal women will have symptoms of PVS. Current treatments approved for this condition all contain estrogen, administered either orally or locally in the vagina. Other currently available SERMs do not have an effect on vaginal tissue and may induce hot flashes.

About QuatRx

QuatRx Pharmaceuticals is focused on the discovery, licensing, development and commercialization of compounds in the endocrine, metabolic and cardiovascular therapeutic areas. In addition to Ophena(TM), QuatRx has three other product candidates in active cl
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. Monitoring Patient Glucose Levels: New Advances in software make it easier
6. Managing Preanalytical Processes for Patient Safety
7. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
8. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... LAVAL, Quebec , April 1, 2015 ... Salix "), a wholly owned subsidiary of Valeant Pharmaceuticals ... that it today provided a Notice of Fundamental Changes, ... Notice, Notice of Execution of Supplemental Indenture and Offer ... its 1.5% Convertible Senior Notes due 2019 (the " ...
(Date:4/1/2015)... BEDFORD, Mass. , April 1, 2015  Hologic, ... has notified holders of the 2.00% Convertible Exchange Senior ... 23, 2010, and Wilmington Trust Company, the trustee, paying ... are eligible to convert the notes.  This conversion right ... governing the notes dated as of December 10, 2007, ...
(Date:4/1/2015)...  The first national study to look at ... attention-deficit/hyperactivity disorder (ADHD) among children ages 4-17 shows ... ADHD were receiving behavioral therapy in 2009-2010 . ... (CDC) study, "Treatment of Attention-Deficit/Hyperactivity Disorder among Children ... The Journal of Pediatrics provides a ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... www.ecardio.com ) announces three executive appointments in an effort to ... patients they serve. "The continued growth that eCardio ... an opportunity to expand the roles of three members of ... Executive Officer. Robert Jordan, Executive Vice President, will ...
... 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... and preventive vaccines against cancers and infectious diseases, announced ... and electroporation delivery technology at the 14th Annual Meeting ... to be held May 18-21 in Seattle, Washington at ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 2Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 3Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 4
(Date:4/1/2015)... (PRWEB) April 01, 2015 New ... joined by other First Spouses from across the ... on March 21, 2015, World Down Syndrome Day(WDSD), ... the rapidly advancing area of Down syndrome cognition ... states included Alabama, Alaska, American Samoa, Arizona, California, ...
(Date:4/1/2015)... Altamonte Springs, FL (PRWEB) April 01, 2015 ... the nation’s leading innovative specialty pharmacies, has released a ... the latest treatment guidelines for treating chronic hepatitis C ... up-to-date treatment guidelines based on information from the American ... other credible, scientific sources. , Numerous new direct-acting oral ...
(Date:4/1/2015)... 01, 2015 Dr Roz Kamani, a ... is now offering her patients an opportunity to learn ... participate in “Beauty Days”, which is an exclusive VIP ... Kamani’s Kitsilano Skin Care Clinic. It is attended by ... about the latest products and services that are on ...
(Date:4/1/2015)... April 01, 2015 South Florida’s newest ... Certificate of Authority (PCOA) approval from the State of ... the ongoing development of a retirement community that will ... wellness and spiritual development. , America’s aging population is ... the housing needs of seniors, according to a recent ...
(Date:4/1/2015)... 01, 2015 Health Advocate™, Inc., the ... subsidiary of West Corporation, today launched its new Health ... and through the Health Advocate member website, features ... and stay, healthy. , “We’re pleased to introduce this ... public,” said Martin Rosen, Executive Vice President, Health Advocate. ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... assistance from the San Diego Supercomputer Center at UC ... creation of customized therapies for virulent flu strains that ... this week in Nature Communications , could aid ... ,pockets., Using powerful computer simulations on SDSC,s new ...
... at the University of Washington (UW) in Seattle have ... The achievement opens new possibilities for molecular medicine researchers ... epilepsy, and heart rhythm disturbances. Sodium channels are ... as brain nerve cells or beating heart cells ...
... July 13 (HealthDay News) -- For patients taking the heart ... not cause more incidents of thyroid dysfunction than the brand-name ... there is no difference between the two drugs, according to ... Medical Association Journal) . Amiodarone, a drug used to ...
... A study published in the July issue of ... among hypertensive patients with coronary artery disease, chronic self-reported ... an increased risk of adverse events during long-term follow-up. ... pain. Researchers from the Division of Cardiovascular Medicine, ...
... In a result that will fundamentally change approaches to ... that individuals at high risk for HIV infection who ... either the antiretroviral medication tenofovir or tenofovir in combination ... those who received a placebo pill. These findings are ...
... Reinberg HealthDay Reporter , TUESDAY, July 12 ... make getting dental care difficult for children and adolescents ... Sandra L. Decker, senior service fellow in the ... for Disease Control and Prevention, found that in states ...
Cached Medicine News:Health News:UC Irvine study points to new approach to influenza's antiviral resistance 2Health News:Atomic structure discovered for a sodium channel that generates electrical signals in living cells 2Health News:Atomic structure discovered for a sodium channel that generates electrical signals in living cells 3Health News:Atomic structure discovered for a sodium channel that generates electrical signals in living cells 4Health News:Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid 2Health News:Long-term NSAID use by hypertensive patients with CAD increases risk of adverse events 2Health News:Pivotal study in Africa finds that HIV medications prevent HIV infection 2Health News:Pivotal study in Africa finds that HIV medications prevent HIV infection 3Health News:Dental Care for Kids on Medicaid Varies by Fees Each State Sets 2Health News:Dental Care for Kids on Medicaid Varies by Fees Each State Sets 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: